APA (7th ed.) Citation

Bourner, J., Vaillant, M., Salam, A. P. A., Jaspard, M., Fritzell, C., Jacob, S. T., . . . Olliaro, P. (2025). Adaptive Design for Phase II/III Platform Trial of Lassa Fever Therapeutics. Emerging Infectious Diseases, 31(2), 9-16. https://doi.org/10.3201/eid3102.240251

Chicago Style (17th ed.) Citation

Bourner, Josephine, et al. "Adaptive Design for Phase II/III Platform Trial of Lassa Fever Therapeutics." Emerging Infectious Diseases 31, no. 2 (2025): 9-16. https://doi.org/10.3201/eid3102.240251.

MLA (9th ed.) Citation

Bourner, Josephine, et al. "Adaptive Design for Phase II/III Platform Trial of Lassa Fever Therapeutics." Emerging Infectious Diseases, vol. 31, no. 2, 2025, pp. 9-16, https://doi.org/10.3201/eid3102.240251.